Investors Heavily Search DexCom, Inc. (DXCM): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to DexCom (DXCM). This makes it worthwhile to examine what the stock has in store.
DexCom (DXCM) Soars 9.8%: Is Further Upside Left in the Stock?
DexCom (DXCM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the r...
S&P 500 Gains and Losses Today: Dexcom Soars as FDA Approves New Glucose Monitor
Major U.S. equities indexes advanced after Federal Reserve Chair Jerome Powell testified in Congress that the central bank is still likely to cut interest rates at some point in 2024.
DexCom's (DXCM) Stelo Glucose Biosensor Receives FDA Approval
DexCom's (DXCM) Stelo receives FDA clearance, which makes it the first FDA-approved glucose biosensor to be available over the counter.
DexCom (DXCM) Rises As Market Takes a Dip: Key Facts
In the most recent trading session, DexCom (DXCM) closed at $122.30, indicating a +0.46% shift from the previous trading day.
Is DexCom (DXCM) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) an...
Here is What to Know Beyond Why DexCom, Inc. (DXCM) is a Trending Stock
Zacks.com users have recently been watching DexCom (DXCM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
DexCom (DXCM) Beats on Q4 Earnings, Strong CGM Demand Continues
DexCom's (DXCM) fourth-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.
DexCom, Inc. (DXCM) Q4 2023 Earnings Call Transcript
DexCom, Inc. (DXCM) Q4 2023 Earnings Call Transcript
DexCom (DXCM) Reports Q4 Earnings: What Key Metrics Have to Say
The headline numbers for DexCom (DXCM) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street est...
Dexcom beats profit estimates on strong demand for glucose monitors
Glucose monitor maker Dexcom beat analyst estimates for fourth-quarter earnings on Thursday, helped by strong demand for its continuous glucose monitoring (CGM) systems.
DexCom (DXCM) Launches One+ Real-time CGM System in Europe
DexCom (DXCM) unveils its new CGM system, Dexcom ONE+, which is set to provide easy and effective care to diabetic patients.
DexCom (DXCM) to Report Q4 Earnings: Is a Beat in Store?
DexCom's (DXCM) fourth-quarter 2023 results are likely to reflect rising volumes across all channels.
DexCom (DXCM) Increases Despite Market Slip: Here's What You Need to Know
In the closing of the recent trading day, DexCom (DXCM) stood at $121.35, denoting a +0.46% change from the preceding trading day.
Related Companies